BCL-XL directly modulates RAS signalling to favour cancer cell stemnessSophie de Carné Trécesson, Philippe Juin|Nature Communications|2017Cited by 46
Cancer associated fibroblasts mitigate the efficacy of the combination of chemotherapy and BCL-xL targeting in triple negative breast cancer cellsFrédérique Souazé, Philippe Juin|Research Square|2024Cited by 0
EGFR/TBK1-dependent mitochondrial quality control contributes to acquired resistance to temozolomideLisenn Lalier-Bretaudeau, Philippe Juin|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0